Cancer Immunology, Immunotherapy

, Volume 36, Issue 5, pp 281–292 | Cite as

Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72

  • K. Irvine
  • J. Schlom
Original articles


The use of anti-idiotypic antibodies as immunogens represents one potential approach to active specific immunotherapy of cancer. Two panels of syngeneic monoclonal anti-idiotypic antibodies were generated. One panel was directed against mAb CC49 and the other to mAb COL-1. mAb CC49 recognizes the pancarcinoma antigen (Ag), tumor-associated glycoprotein-72 (TAG-72), and mAb COL-1 recognizes carcinoembryonic antigen (CEA). Seven anti-idiotypic (AI) antibodies (Ab2) designated AI49-1–7 were generated that recognize the variable region of mAb CC49. These mAb were shown to inhibit the interaction of mAb CC49 (Ab1) with TAG-72 (Ag). Five anti-idiotypic antibodies designated CAI-1–5 were also generated to the anti-CEA mAb, COL-1 (Ab1). These Ab2 were shown to inhibit the interaction between COL-1 (Ab1) and CEA (Ag). Immunization of mice, rats, and rabbits with Ab2 directed against CC49 or COL-1 could not elicit specific Ab3 humoral immune responses, i.e., antibody selectively reactive with their respective target antigens. However, immunization of mice with the CC49 anti-idiotypic antibody (Ab2), designated AI49-3, could induce a delayed-type hypersensitivity response (DTH) specific for tumor cells that express TAG-72. Similarly, immunization of mice with an anti-idiotypic antibody directed against COL-1, designated CAI-1, could induce specific DTH cell-mediated immune responses to murine tumor cells that express human CEA on their surface. These results thus demonstrate that while some anti-idiotype mAb may not be potent immunogens in eliciting Ab3 humoral responses, they are capable of eliciting specific cellular immune responses against human carcinoma-associated antigens. This type of mAb may ultimately be useful in active immunotherapy protocols for human carcinoma.

Key words

Carcinoembryonic antigen Anti-idiotype antibody Delayed-type hypersensitivity 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barnd DL, Kerr LA, Metzgar RS, Finn OJ (1988) Human tumor-specific cytotoxic T-cell lines generated from tumor-draining lymph node infiltrate. Transplant Proc 20: 339Google Scholar
  2. 2.
    Beatty JD, Williams LE, Yamauchi D, Morton BA, Hill R, Beatty BG, Paxton RJ, Merchant B, Shively JE (1990) Presurgical imaging with indium-labeled anti-carcinoembryonic antigen for colon cancer staging. Cancer Res 50 [Suppl]: 922sGoogle Scholar
  3. 3.
    Bhattacharya-Chatterjee S, Biddle W, Foon K, Kohler H (1990) Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoma embryonic antigen. J Immunol 145: 2758Google Scholar
  4. 4.
    Chen ZJ, Yang H, Yamada M, Kageshita T, Zhen Y, Bae JW, Mittelman A, Ferrone S (1990) In: Lotze MT, Finn OJ (eds) Cellular immunity and the immunotherapy of cancer. Wiley-Liss, New York, pp 351–359Google Scholar
  5. 5.
    Colcher D, Horan-Hand P, Nuti M, Schlom J (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 78: 3199Google Scholar
  6. 6.
    Colcher D, Esteban JM, Carrasquillo JA, Sugarbaker P, Reynolds JC, Bryant G, Larson SM, Schlom J (1987) Complementation of intracavitary and intravenously administered mAb B72.3 in patients with carcinoma. Cancer Res 47: 4218Google Scholar
  7. 7.
    Dunn PL, Johnson CA, Styles JM, Pease SS, Dean CJ (1987) Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge. Immunology 60: 181Google Scholar
  8. 8.
    Durrant LG, Denton GWL, Jacobs E, Mee M, Moss R, Austin EB, Baldwin RW, Hardcastle JD, Robins RA (1992) An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral immune responses directed against human colorectal tumours. Int J Cancer 50: 811Google Scholar
  9. 9.
    Ertl HC, Finberg RW (1984) Sendai virus-specific T cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone. Proc Natl Acad Sci USA 81: 2850Google Scholar
  10. 10.
    Esteban JM, Colcher D, Sugarbaker P, Carrasquillo JA, Bryant G, Thor A, Reynolds JC, Larson SM, Schlom J (1987) Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered mAb B72.3. Int J Cancer 39: 50Google Scholar
  11. 11.
    Fox BA, Spiess PF, Kasid A, Puri R, Mule JJ, Weber JS, Rosenberg SA (1990) In vitro and in vivo anti-human properties of a T-cell clone generated from tumor-infiltrating lymphocytes. J Biol Response Mod 9: 499Google Scholar
  12. 12.
    Fraker PJ, Speck JC Jr (1978) Protein and cell membrane iodinations with a sparingly soluble chloramid 1,3,4,6-tetrachloro-3a,6a-diphenylglycouril. Biochem Biophys Res Commun 80: 849Google Scholar
  13. 13.
    Gaida F-J, Fenger U, Wagener C, Neumaier M (1992) A monoclonal anti-idiotypic antibody bearing the image of an epitope specific to the human carcinoembryonic antigen. Int J Cancer 51: 459Google Scholar
  14. 14.
    Gold P, Freedman SO (1965) Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122: 467Google Scholar
  15. 15.
    Goldenberg DM, Goldenberg H, Sharkey RM, Higginbotham-Ford E, Lee RE, Swayne LC, Burger KL, Tsai D, Horowitz J, Hall TC, Pinsky CM, Hansen HJ (1990) Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with123I or99mTc. Cancer Res [Suppl] 50: 909sGoogle Scholar
  16. 16.
    Grych JM, Capron M, Lambert PH, Dissous C, Torres S, Capron A (1985) An anti-idiotypic vaccine against experimental schistomiasis. Nature 316: 76Google Scholar
  17. 17.
    Herlyn M, Ross AH, Iliopoulos D, Koprowski H (1987) Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A. Eur J Immunol 7: 1649Google Scholar
  18. 18.
    Herlyn D, Benden A, Kane M, Somasundaram R, et al (1991) Anti-idiotype cancer vaccines: pre-clinical and clinical studies. In Vivo 5: 615Google Scholar
  19. 19.
    Herzenberg LA, Herzenberg LA, Milstein C (1978) Cell hybrids of myelomas and antibody forming cells and T lymphocytes with T cells. In: Handbook of experimental immunology. Blackwell Scientific Publications, London, p 25.1Google Scholar
  20. 20.
    Jerne NK (1974) Towards a network theory of the immune system. Annu Rev Immunol 125: 373Google Scholar
  21. 21.
    Johnson VG, Schlom J, Paterson AJ, Bennet J, Magnani JL, Colcher D (1986) Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 46: 850Google Scholar
  22. 22.
    Kahn M, Hellstrom I, Estin CD, Hellstrom KE (1989) Monoclonal anti-idiotypic antibodies to the p97 human melanoma antigen. Cancer Res 49: 3157Google Scholar
  23. 23.
    Kohler G, Milstein C (1976) Derivation of specific antibody producing tissue culture and tumor cell lines by cell fusion. Eur J Immunol 6: 511Google Scholar
  24. 24.
    Kohler H, Kieber-Emmons T, Srinivasav S, Kaveri S, Morrow WJW, Muller S, Kang C-Y, Raychaudhuri S (1989) Short analytical review: revised immune network concepts. Clin Immunol Immunopathol 52: 104Google Scholar
  25. 25.
    Koprowski H, Herlyn D, Lubeck M, DeFreitas E, Sears HF (1984) Human anti-idiotypic antibodies in cancer patients. Is the modulation of the immune response beneficial to the patient? Proc Natl Acad Sci USA 81: 216Google Scholar
  26. 26.
    Kuroki M, Greiner JW, Simpson JF, Primus FJ, Guadagni F, Schlom J (1989) Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies. Int J Cancer 44: 208Google Scholar
  27. 27.
    Kuroki M, Fernsten PD, Wunderlich D, Colcher D, Simpson JF, Poole DJ, Schlom J (1990) Serologic mapping of the TAG-72 tumor-associated antigen employing 19 distinct monoclonal antibodies. Cancer Res 50: 4872Google Scholar
  28. 28.
    Kusama M, Kageshita T, Chen ZJ, Ferrone S (1989) Characterization of syngeneic anti-idiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies. J Immunol 143: 3844Google Scholar
  29. 29.
    Lee VK, Harriott TG, Kuchroo VK, Halliday WJ, Hellstrom I, Hellstrom KE (1985) Monoclonal anti-idiotope antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity. Proc Natl Acad Sci USA 82: 6286Google Scholar
  30. 30.
    Losman M, Hansen H, Sharkey R, Goldenberg DM, Monestier M (1988) Human response against NP-4, a mouse antibody to carcinoembryonic antigen: human anti-idiotypic antibodies mimic an epitope on the tumor antigen. Proc Natl Acad Sci USA 85: 1052Google Scholar
  31. 31.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265Google Scholar
  32. 32.
    Maguire RT, Schmelter RF, Pacucci VL, Conklin JJ (1989) Immunoscintography of colorectal adenocarcinoma. Results with a site-specifically radiolabeled B72.3 (111In-CYT-103). Antibody Immunoconj Radiopharmacol 2: 257Google Scholar
  33. 33.
    Maloney DG, Kaminski MS, Burowski D, Haimovich J, Levy R (1985) Monoclonal anti-idiotypic antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma 4: 191Google Scholar
  34. 34.
    McNamara MK, Ward RE, Kohler H (1984) Monoclonal anti-idiotypic vaccine against streptococcus pneumonial infection. Science 226: 1325Google Scholar
  35. 35.
    Mellstedt H, Frodin JE, Biberfield P, Fagerberg J, Giscombe R, Hernandez A, Mascucci G, Li S-L, Steinitz M (1991) Patients treated with a monoclonal antibody (Ab1) to the colorectal carcinoma antigen 17-1A develop a cellular response (DTH) to the “internal image of the antigen” (Ab2). Int J Cancer 48: 344Google Scholar
  36. 36.
    Mittelman A, Chen ZJ, Kageshita T, Yang H, Yamada M, Baskind P, Goldberg N, Ahmed T, Arlin Z, Ferrone S (1990) Active specific immunotherapy in patients with melanoma. A clinical trial with mouse monoclonal antibodies elicited with syngeneic anti-high-molecular weight-melanoma associated antigen monoclonal antibodies. J Clin Invest 86: 2136Google Scholar
  37. 37.
    Monestier M, Debbas ME, Goldenberg DM (1989) Syngeneic anti-idiotypic monoclonal antibodies to murine anti-carcinoembryonic antigen monoclonal antibodies. Cancer Res 49: 123Google Scholar
  38. 38.
    Muraro R, Wunderlich D, Thor A, Noguchi P, Cunningham R, Schlom J (1985) Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res 45: 5768Google Scholar
  39. 39.
    Muraro R, Nuti M, Natali PG, Bigotti A, Simpson JF, Primus FJ, Colcher D, Greiner JW, Schlom J (1989) A monoclonal antibody (D612) with selective reactivity for malignant and normal gastrointestinal epithelium. Int J Cancer 43: 598Google Scholar
  40. 40.
    Nissonoff A, Lamoyi E (1981) Implications of the presence of an internal image of the antigen on an anti-idiotypic antibody. Clin Immunol Immunopathol 21: 397Google Scholar
  41. 41.
    Rajewsky K, Takemori T (1983) Genetics, expression and function of idiotype. Annu Rev Immunol 1: 569Google Scholar
  42. 42.
    Raychaudhuri S, Saeki Y, Fuji H, Kohler H (1986) Tumor specific idiotypic vaccines: I. Generation and characterization of an internal image tumor antigen. J Immunol 137: 1743Google Scholar
  43. 43.
    Reagan KJ, Wunner WH, Wiktor TJ, Koprowski H (1983) Anti-idiotypic antibodies induce neutralizing antibodies to rabies virus glycoprotein. J Virol 48: 660Google Scholar
  44. 44.
    Robbins PF, Kantor J, Salgaller M, Hand P, Fernsten PD, Schlom J (1991) Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res 51: 3657Google Scholar
  45. 45.
    Sharkey RM, Goldenberg DM, Goldenberg H, Lee RE, Ballance C, Pawlyk D, Varga D, Hansen HJ (1990) Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. Cancer Res 50: 2823Google Scholar
  46. 46.
    Sheer DG, Schlom J, Cooper H (1988) Purification and composition of the human tumor associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Cancer Res 48: 6811Google Scholar
  47. 47.
    Snedecor GW, Cochran WG (1989) In: Statistical methods, 8th edn. Iowa State Press, Ames, Iowa, p 132Google Scholar
  48. 48.
    Steward AM, Nixon D, Zamcheck N, Aisenberg A (1974) Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer 33: 1246Google Scholar
  49. 49.
    Thor A, Viglione MJ, Muraro R, Ohuchi N, Schlom J, Gorstein F (1987) Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues. Int J Gynecol Pathol 6: 235Google Scholar
  50. 50.
    Tom BH, Rutzky LP, Jakstys MM (1976) Human colonic adenocarcinoma cells: I. Establishment and description of a new line. In Vitro 12: 180Google Scholar
  51. 51.
    Tsujisaki M, Imai K, Tokuchi S, Hanzawa Y, Ishida I, Kitagawa H, Hinoda Y, Yachi A (1991) Induction of antigen-specific immune response with the use of anti-idiotypic monoclonal antibodies to carcinoembryonic antigen antibodies. Cancer Res 51: 2599Google Scholar
  52. 52.
    Viale G, Flamini G, Grassi F, Buffa R (1989) Idiotypic replica of an anti-human tumor-associated antigen monoclonal antibody. Analysis of monoclonal Ab1 and Ab3 fine specificity. J Immunol 15: 4338Google Scholar
  53. 53.
    Vincent RG, Chu TM (1978) Carcinoembryonic antigen in patients with carcinoma of the lung. J Thorac Cardiovasc Surg 66: 320Google Scholar
  54. 54.
    Wettendorf M, Iliopoulos D, Tempero M, Kay D, DeFreitas E, Koprowski H, Herlyn D (1989) Idiotypic cascades in cancer patients treated with MoAb CO171A. Proc Natl Acad Sci USA 86: 3787Google Scholar
  55. 55.
    Wolf BC, Salem RR, Sears HF, Horst DA, Lavin PT, Herlyn M, Itzkowitz SH, Schlom J, Steele GD (1989) The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa: an immunohistochemical analysis of regional distribution. Am J Pathol 135: 111Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • K. Irvine
    • 1
  • J. Schlom
    • 1
  1. 1.Laboratory of Tumor Immunology and BiologyNational Cancer Institute, National Institutes of HealthBethesdaUSA

Personalised recommendations